Log in or Sign up for Free to view tailored content for your specialty!
Cornea/External Disease News
Preop LipiFlow improves meibomian gland function in patients with range of vision IOLs
Presurgical treatment with LipiFlow improved meibomian gland function in patients with range of vision IOLs, according to a study.
Bausch + Lomb acquires Blink eye drop products from Johnson & Johnson Vision
An affiliate of Bausch + Lomb acquired the over-the-counter Blink product line of eye and contact lens drops from Johnson & Johnson Vision, according to a press release.
Log in or Sign up for Free to view tailored content for your specialty!
Healio presents top five ophthalmology items of the week
Healio’s top ophthalmology items this week covered the accuracy of self-administered eye drops and the efficacy of thickening corneas before cross-linking.
Reverse four-throw pupilloplasty allows knot formation on posterior surface of iris
In this column, we will describe a simple and novel method of performing a pupilloplasty procedure that allows adequate pupil reconstruction.
Man presents with 2 weeks of blurry vision, dryness, redness in left eye
A 30-year-old man presented with chief complaints of blurry vision, dryness and redness in the left eye for 2 weeks. He was previously started on a lubricating ointment and Tobradex drops with some improvement but not complete resolution.
BLOG: AQI: The New Dry Eye Index
Apparently, it’s time for us to add another index to our DED armamentarium.
VIDEO: Thinner corneas can be thickened before cross-linking
SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Zeba A. Syed, MD, ABO, discusses a study that evaluated the thickening of corneas before corneal cross-linking.
VIDEO: Cryopreserved amniotic membrane beneficial before cataract surgery
In this Healio Video Perspective from the ASCRS meeting, Jeff Wongs, MD, discusses a study that investigated the benefits of cryopreserved amniotic membrane to restore the ocular surface to a healthy state.
BLOG: Brent Saunders is back! B+L acquires Xiidra
Is this what it’s like to be in junior high school when the new kid asks the prettiest girl to the dance?
Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis
Novartis has entered a transaction of up to $2.5 billion to divest ‘front of eye’ ophthalmology assets, including Xiidra, to Bausch + Lomb, according to a company press release.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read